In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

ESC Congress 365

Review thousands of videos, slides, abstracts and reports from previous ESC Congresses

online, anytime, without subscription

READ MORE

Congress in Review

ESC Congress

Scientifically-vetted articles summarising key findings presented at congresses organised by the ESC

2017 editions now available



ESC CONGRESS 2017 IN REVIEW

ESC Congress 2017 in Review - Main edition

LR_ESC 2017_cover_MAIN.jpg

Top advances and key clinical trials contained in this report include:

  • COMPASS
  • CANTOS
  • RE-DUAL PCI
  • ORION-1

The feature article provides an overview of the new ESC Clinical Practice Guidelines released during the Congress, covering the management of AMI in patients who present with STEMI, the diagnosis and treatment of PADs, the management of valvular heart disease, and a focused update on dual antiplatelet therapy in patients with CAD.

Also included are articles that contain information on selected areas of cardiovascular medicine including cholesterol lowering therapy for primary and secondary prevention, a look at future therapies for heart failure, and the prevention and management of acute stroke.

Read the full report here

This publication is supported by SERVIER

ESC Congress 2017 in Review - Focus on Arrhythmias

LR_ESC 2017_cover_ARR.jpg

Top advances and key clinical trials contained in this report include:

  • CASTLE AF
  • IMPACT AF
  • Results from the AFinder Program

The feature article takes a closer look at current and evolving treatments for AF including a hybrid ablation approach that combines the strengths and minimises the limitations of either surgical or catheter ablation alone, pulmonary vein isolation, and antiarrhythmic drug therapy.

The issue also contains articles that reflect on four decades of ICD therapy and indications for 2017, as well as the use of anticoagulant therapy for cardioversion of AF.

Read the full report here

This publication is supported by Boehringer Ingelheim

ESC Congress 2017 in Review - Focus on CAD & ACS

LR_ESC 2017_cover_CAD.jpg

Top advances and key clinical trials contained in this report include:

  • COMPASS
  • RE-DUAL PCI
  • VALIDATE-SWEDEHEART
  • DETO2X-AMI

The feature article reviews the newly released 2017 ESC Clinical Practice Guidelines for the Management of AMI in Patients Presenting with STEMI; highlighting changes from the 2012 guidelines.

The issue also contains articles that discuss the use of pharmacotherapy after STEMI and the use of P2Y12 inhibitors for the treatment of patients with ACS.

Read the full report here

This publication is supported by Bayer AG

ESC Congress 2017 in Review - Focus on Interventions & Peripheral Circulation

LR_ESC 2017_cover_Interv.jpg

Top advances and key clinical trials contained in this report include:

  • COMPASS
  • A subanalysis of FAME 1 and 2
  • Insights from the MAUDE database

The feature article concentrates on the newly released 2017 ESC Clinical Practice Guidelines on the Diagnosis and Treatment of PADs. Changes from the 2011 guidelines include the use of a “vascular team” for multidisciplinary management, risk stratification for asymptomatic carotid disease, and a focus on lower extremity disease.

The issue also contains articles explore the 2017 ESC Clinical Practice Guidelines focused update on dual antiplatelet therapy, and the management of PAD patients who also have concomitant cardiac diseases, including CAD, atrial fibrillation, and heart failure.

Read the full report here

This publication is supported by Bayer AG

ESC CONGRESS 2016 IN REVIEW

ESC Congress 2016 in Review - Main edition

ESC Congress 2016 in Review

The top advances and key clinical trials contained in these reports include:

  • The DANISH trial
  • PRAGUE-18
  • ANNEXA-4
  • A landmark analysis illustrating that LDL-C and systolic blood pressure have independent, multiplicative, and cumulative causal effects on the risk of CV events

The featured article provides a topline summary of the 4 new ESC Clinical Practice Guidelines on atrial fibrillation, cardiovascular disease prevention, dyslipidemia, and heart failure.

Also included are articles on new drugs being developed for the treatment of heart failure and the reversal of the effects of non-vitamin K oral anticoagulants.

Read the full report here

ESC Congress 2016 in Review is supported by SERVIER in the form of an unrestricted educational grant.

 

ESC Congress 2016 in Review - Focus on Arrhythmias

ESC Congress 2016 in Review - Focus on Arrhytmmias

The top advances and key clinical trials contained in these reports include:

  • ENSURE-AF
  • BEYOND NORWAY
  • ORBIT-AF II

The featured article is dedicated to the 2016 ESC Clinical Practice Guidelines on Atrial Fibrillation (AF).

You will also find information on reducing the burden of AF through prevention and treatment, updates on treating AF in a complex environment, and the use of miniature leadless pacing systems.

Also included are articles on new drugs being developed for the treatment of heart failure and the reversal of the effects of non-vitamin K oral anticoagulants.

Read the full report here

ESC Congress 2016 in Review - Focus on Arrhythmias is supported by Daiichi Sankyo Europe GmbH in the form of an unrestricted educational grant.

 

ESC CONGRESS 2015 IN REVIEW

ESC Congress 2015 in Review - Main edition

Top advances and key clinical trials contained in this report include:

  • Two analyses of the IMPROVE-IT study
  • The TECOS trial
  • The PATHWAY-2 trial
  • A topline summary of the 5 new ESC Guidelines released during the Congress: pericardial diseases, ventricular arrhythmias and sudden cardiac death, pulmonary hypertension, infective endocarditis, and non–ST segment elevation acute coronary syndromes.
  • The therapeutic updates on atrial fibrillation, interventional cardiology, and the clinical challenges associated with the use of anticoagulants.

Read the full report here

ESC Congress 2015 in Review is supported by SERVIER in the form of an unrestricted educational grant.

 

NEW in 2015: ESC Congress 2015 in Review - Focus on Prevention

Top advances and key clinical trials contained in this report include:

  • Findings from EUROASPIRE III and IV
  • The SUPPORT trial
  • Data from the prospective, international, cohort VISION study
  • Feature articles review advances in the management of CVD risk, personalised medicine in CVD management, the role of e-cigarettes in smoking cessation, the Global Cardiovascular Nursing Leadership Forum (mobilising nurse leaders to promote prevention of CVD worldwide), and some important interventions that have been initiated in order to reach the World Heart Federation’s goal of a 25% reduction in premature deaths from CVD by 2025.
  • Also included are therapeutic updates that contain in depth information on cholesterol-lowering goals and how to achieve them with statins and other treatment options, old and new.


 Read the full report here

 ESC Congress in Review - Focus on Prevention is supported by Amgen

 

ESC Congress 2015 in Review Focus on Arrhythmias

ESC Congress in review arrhythmiasTop advances and key clinical trials contained in this report include:

  • The LEADLESS II trial of a self-contained leadless cardiac pacemaker
  • The BELIEF study
  • The EAST-AF Trial
  • AEGEAN trial of a proactive education program to encourage patient adherence
  • Feature articles look at the use of catheter ablation in AF and explore clinical guidelines for pacing, implantable cardioverter defibrillators, and cardiac resynchronization therapy.
  • Also included are therapeutic updates that contain in depth information on practical issues related to leadless, subcutaneous, and wearable ICDs, and address clinical questions around the use of novel oral anticoagulants for stroke prevention in patients with nonvalvular AF.

     

    Read the full report here

    ESC Congress in Review - Focus on Arrhythmias is supported by Daiichi Sankyo Europe GmbH in the form of an unrestricted educational grant.

ESC CONGRESS 2014 IN REVIEW

Read the full report here
View the table of contents here

 

New in 2014: ESC Congress in Review - Focus on Arrhythmias

Read the full report here
View the table of contents here

EHRA EUROPACE-CARDIOSTIM 2015 in Review

Top advances and key clinical trials contained in this report include:

  • Summaries of two studies of the leadless Micra Transcatheter Pacing System,
  • The prospective CARDIO-FIT study, and
  • Two registry studies that examined the use of NOAC use in patients with AF undergoing radiofrequency catheter ablation.

Read the full report here

EHRA EUROPACE-CARDIOSTIM 2015 in Review  is supported by Daiichi Sankyo Europe GmbH in the form of an unrestricted educational grant.